Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Algorhythm Holdings Inc 주요 수익원은 Power and Microwave Technologies이며, 최신 수익 발표에서 수익은 128,697,000입니다. 지역별로는 United States이 Algorhythm Holdings Inc의 주요 시장이며, 수익은 78,584,000입니다.
Sharps Technology Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Algorhythm Holdings Inc의 순손실은 $0입니다.